Tài liệu tham khảo |
Loại |
Chi tiết |
1. Garofalo, A.; Goossens, L.; Baldeyrou, B.; Lemoine, A.; Ravez, S.; Six, P.; David Cordonnier, M.; Bonte, J.; Depreux, P.; Lansiaux, A.; Goossens, J.Design, synthesis, and DNA-binding of N-alkyl (anilino)quinazoline derivatives.Journal of Medicinal Chemistry. 2010, 53, 8089-8103 |
Sách, tạp chí |
Tiêu đề: |
Design, synthesis, and DNA-binding of N-alkyl (anilino)quinazoline derivatives |
|
2. Alafeefy, A. M. Some newquinazolin-4(3H) one derivatives synthesis and antitumor activity. J. Saudi Chem. Soc. 2011, 15, 337-343 |
Sách, tạp chí |
Tiêu đề: |
Some newquinazolin-4(3H) one derivatives synthesis and antitumor activity." J. Saudi Chem. Soc. 2011, "15 |
|
3. Carmi, C.; Cavazzoni, A.; Vezzosi, S.; Bordi, F.; Vacondio, F.; Silva, C.; Rivara, S.; Lodola, A.; Alfieri, R. R.; La Monica, S.; Galetti, M.; Ardizzoni, A.;Petronini, P. G.; Mor, M. Novel irreversible epidermal growth factor receptor inhibitors by chemical modulation of the cysteine-trap portion. Journal of Medicinal Chemistry. 2010, 53, 2038-2050 |
Sách, tạp chí |
Tiêu đề: |
Novel irreversible epidermal growth factor receptor inhibitors by chemical modulation of the cysteine-trap portion." Journal of Medicinal Chemistry. 2010, "53 |
|
4. Singh, K.; Sharma, P.; Kumar, A.; Chaudhary, A.; Roy, R. 4-Aminoquinazoline Analogs: A Novel Class of Anticancer Agents Mini Rev. Journal of Medicinal Chemistry. 2013, 13, 1177-1194 |
Sách, tạp chí |
Tiêu đề: |
A Novel Class of Anticancer Agents Mini Rev". Journal of Medicinal Chemistry. 2013, "13 |
|
5. Sharma, S. V.; Bell, D. W.; Settleman, J.; Haber, D. A. Epidermal growth factor receptor mutations in lung cancer. Nat. Rev. Cancer. 2007, 7, 169 |
Sách, tạp chí |
Tiêu đề: |
Epidermal growth factor receptor mutations in lung cancer |
|
6. Zhang, H.; Berezov, A.; Wang, Q.; Zhang, G.; Drebin, J.; Murali, R.; Greene, M. I. ErbB receptors: from oncogenes to targeted cancer therapies. J. Clin. Invest., 2007, 117, 2051 |
Sách, tạp chí |
Tiêu đề: |
ErbB receptors: from oncogenes to targeted cancer therapies |
|
7. Avizienyte, E.; Ward, R. A.; Garner, A. P. Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations. Biochem. J. 2008, 415, 197 |
Sách, tạp chí |
Tiêu đề: |
Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations |
|
8. Li, Y. B.; Wang, Z. Q.; Yan, X.; Chen, M. W.; Bao, J. L.; Wu, G. S.; Ge, Z. M.; Zhou, D. M.; Wang, Y. T.; Li, R. T. Cancer Lett. 2013, 340, 88 |
Sách, tạp chí |
Tiêu đề: |
Cancer Lett. "2013, "340 |
|
10. Mendelsohn, J.; Baselga, J. The EGF receptor family as targets for cancer therapy. Oncogene 2000, 19, 6550-6565 |
Sách, tạp chí |
Tiêu đề: |
The EGF receptor family as targets for cancer therapy |
|
11. Ciardiello, F.; Tortora, G. EGFR antagonists in cancer treatment. N.Engl. J. Med. 2008, 358, 1160-1174 |
Sách, tạp chí |
Tiêu đề: |
EGFR antagonists in cancer treatment |
|
12. Harandi, A.; Zaidi, A. S.; Stocker, A. M.; Laber, D. A. Clinical Efficacy and Toxicity of Anti-EGFR Therapy in Common .Cancers. Journal of Oncology. 2009, 1-14 |
Sách, tạp chí |
Tiêu đề: |
Clinical Efficacy and Toxicity of Anti-EGFR Therapy in Common |
|
13. Gschwind, A.; Fischer, O. M.; Ullrich A. The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat. Rev. Cancer 2004, 4, 361-370 |
Sách, tạp chí |
Tiêu đề: |
The discovery of receptor tyrosine kinases: targets for cancer therapy |
|
14. Cheng, W.; Yuan, Y.; Qui, N.; Peng, P.; Sheng, R.; Hu, Y. Identification of novel 4-anilinoquinazoline derivatives as potent EGFR inhibitors both under normoxia and hypoxia. Bioorg. Journal of Medicinal Chemistry. 2014, 22, 6796- 6805 |
Sách, tạp chí |
Tiêu đề: |
Identification of novel 4-anilinoquinazoline derivatives as potent EGFR inhibitors both under normoxia and hypoxia |
|
15. Yun, C. H.; Boggon, T. J.; Li, Y. Q.; Woo, M. S.; Greulich, H.; Meyerson, M.; Eck, M. Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. J. Cancer Cell 2007, 11, 217 |
Sách, tạp chí |
Tiêu đề: |
Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity |
|
16. Stamos, J.; Sliwkowski, M.X.; Eigenbrot, C. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J. Biol. Chem. 2002, 277, 46265 |
Sách, tạp chí |
Tiêu đề: |
Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor |
|
17. Hu, S.; Xie, G.; Zhang, A. X.; Davis, C.; Long, W; Hu, Y.; Wang, F.; Kang, X.; Tan, F.; Ding, L.; Wang Y. Synthesis and biological evaluation of crown ether fused quinazoline analogues as potent EGFR inhibitors. Bioorg. Med. Chem.Lett. 2012, 22, 6301-6305 |
Sách, tạp chí |
Tiêu đề: |
Synthesis and biological evaluation of crown ether fused quinazoline analogues as potent EGFR inhibitors |
|
18. Zhao, Q.; Shentu, J.; Xu, N.; Zhou, J.; Yang, G.; Yao, Y. Phase I study of icotinib hydrochloride (BPI-2009H), an oral EGFR tyrosine kinase inhibitor, in patients with advanced NSCLC and other solid tumors. Lung Cancer 2011, 73, 195-202 |
Sách, tạp chí |
Tiêu đề: |
Phase I study of icotinib hydrochloride (BPI-2009H), an oral EGFR tyrosine kinase inhibitor, in patients with advanced NSCLC and other solid tumors |
|
19. Sun, Y.; Shi, Y.; Zhang, L.; Liu, X.; Zhou, C.; Zhang, L. A randomized, double- blind phase III study of icotinib versus gefitinib in patients with advanced non- small cell lung cancer (NSCLC) previously treated with chemotherapy (ICOGEN). J. Clin. Oncol. 2011, 29, 7522 (No.15_suppl; abstr 7522) |
Sách, tạp chí |
Tiêu đề: |
A randomized, double-blind phase III study of icotinib versus gefitinib in patients with advanced non-small cell lung cancer (NSCLC) previously treated with chemotherapy (ICOGEN) |
|
22. Zhao, F.; Lin, Z.; Wang, F.; Zheng, X.; Yun, H.; Zhao, W.; Dong, X. Four- membered heterocycles-containing 4-anilino-quinazoline derivatives as epidermal growth factor receptor (EGFR) kinase inhibitors. Bioorg. Med.Chem. Lett. 2013, 23, 5385-5388 |
Sách, tạp chí |
Tiêu đề: |
Four-membered heterocycles-containing 4-anilino-quinazoline derivatives as epidermal growth factor receptor (EGFR) kinase inhibitors |
|
23. Zuo, S.-J.; Zhang, S.; Mao, S.; Xie, X.-X.; Xiao, X.; Xin, M.-H.; Xuan, W.; He, Y.-Y.; Cao, Y.-X.; Zhang, S.-Q. Combination of 4 anilinoquinazoline, arylurea and tertiary amine moiety to discover novel anticancer agents. Bioorg. Med.Chem. 2016, 24, 179-190 |
Sách, tạp chí |
Tiêu đề: |
Combination of 4 anilinoquinazoline, arylurea and tertiary amine moiety to discover novel anticancer agents |
|